EPI E Z PEN JR (epinephrine) by Viatris is adrenergic alpha-agonists [moa]. First approved in 1987.
Drug data last refreshed 21h ago · AI intelligence enriched 2d ago
EPI E Z PEN JR is an intramuscular epinephrine auto-injector indicated for emergency treatment of anaphylaxis and severe allergic reactions in pediatric patients. The drug works as an alpha-adrenergic agonist, rapidly counteracting the physiological effects of anaphylaxis by increasing heart rate, blood pressure, and airway patency. This is a life-saving emergency medication with immediate onset of action.
Product approaching loss of exclusivity with moderate competitive pressure (30/100), indicating potential downsizing of commercial teams and shift toward cost-containment strategies.
Adrenergic alpha-Agonists
alpha-Adrenergic Agonist
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Continuous Versus Bolus Norepinephrine Administration to Treat Postinduction Hypotension
Study Comparing Glycerin With 1% Lidocaine and Epinephrine Versus Glycerin With 1% Lidocaine Without Epinephrine for the Sclerotherapy of Leg Telangiectasias
Hemodynamic Effects of Norepinephrine Reduction on Critical Closing Pressure in Distributive Shock
Pneumatic Leg Compression and Norepinephrine Requirements in Patients Having Non-cardiac Surgery
Treating Intraoperative Bradycardia in Non-cardiac Surgery Patients With Atropine at Heart Rates Below 60 Versus 30 Beats Per Minute and Norepinephrine Requirements
Worked on EPI E Z PEN JR at Viatris? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Upgrade to Pro to access CMS Part B ASP pricing data and other premium pharma intelligence.
Upgrade to Pro — $25/moWorking on EPI E Z PEN JR offers limited career growth as the product approaches loss of exclusivity, with zero linked job openings currently posted. Career trajectory on this product is likely defensive and operationally focused rather than expansionary, making it suitable for professionals seeking stability in a mature market or preparing for transition to growth-stage products.